Silke Polata

Axillary Surgery in Breast Cancer — Primary Results of the INSEMA Trial

Toralf Reimer, Angrit Stachs, Kristina Veselinovic et al. · New England Journal of Medicine · 2024 · 168 citations

Patient-reported outcomes for the Intergroup Sentinel Mamma study (INSEMA): a randomised trial with persistent impact of axillary surgery on arm and breast symptoms in patients with early breast cancer

Toralf Reimer, Angrit Stachs, Kristina Veselinovic et al. · EClinicalMedicine · 2022 · 88 citations · Full text

De-escalated neoadjuvant pertuzumab plus trastuzumab therapy with or without weekly paclitaxel in HER2-positive, hormone receptor-negative, early breast cancer (WSG-ADAPT-HER2+/HR–): survival outcomes from a multicentre, open-label, randomised, phase 2 trial

Ulrike Nitz, Oleg Gluz, Monika Graeser et al. · The Lancet Oncology · 2022 · 76 citations

Breast Oncology, Medicine, Trastuzumab Therapy +9

Safety of Targeted Axillary Dissection After Neoadjuvant Therapy in Patients With Node-Positive Breast Cancer

Sherko Kuemmel, Joerg Heil, S. Bruz̆as et al. · JAMA Surgery · 2023 · 66 citations · Full text

Systematic symptom screening in patients with advanced cancer treated in certified oncology centers: results of the prospective multicenter German KeSBa project

Friederike Braulke, Servet Para, Bernd Alt‐Epping et al. · Journal of Cancer Research and Clinical Oncology · 2023 · 26 citations · Full text